A First-in-Human Study of AV-001 in Healthy Subjects

Clinical trial NCT04737486 · COMPLETED

Trial details

NCT number: NCT04737486
Sponsor: Vasomune Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Covid19-associated ARDS Covid19 ARDS

Start date: 2020-12-16
Primary completion: 2021-03-10
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.